Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Telfiga M 40mg/50mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Infiga Healthcare

Salt Composition

Telmisartan (40mg) + Metoprolol Succinate (50mg)

Overview Telfiga M 40mg/50mg Tablet ER

Telfiga M 40mg/50mg Extended-Release tablets manage hypertension, reducing the risk of strokes and heart attacks. Early use improves survival rates after a heart attack. For consistent blood levels, take this medication with food daily at the same time, as directed by your physician. Continue treatment even if feeling well; untreated hypertension is often asymptomatic. Discontinuing the medication may worsen your condition. Lifestyle modifications, including regular exercise, weight management, and a healthy diet, further enhance blood pressure control. Closely follow your doctor's instructions. Potential side effects include headache, fatigue, weakness, dizziness, low blood pressure, elevated potassium levels, occasional orthostatic hypotension (possibly with fainting), shortness of breath, nausea, vomiting, and abdominal pain. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly from a seated position. Regular monitoring of blood pressure, blood sugar, kidney function, urea, and electrolytes may be necessary. Inform your doctor about any kidney or liver issues before starting this medication. Pregnant or breastfeeding individuals should consult their physician before use. Always disclose all other medications, particularly those for hypertension or heart conditions.

Primary Ingredients of Telfiga M 40mg/50mg Tablet ER

No text was provided to rewrite.

Uses of Telfiga M 40mg/50mg Tablet ER

Managing elevated blood pressure

Major Benefits of Telfiga M 40mg/50mg Tablet ER:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Telfiga M 40mg/50mg Extended-Release Tablet should be administered with a meal.

Common Side effects of Telfiga M 40mg/50mg Tablet ER:

  • Headache
  • Weakness
  • Dizziness
  • Cold extremities
  • Slow heart rate
  • Increased potassium level in blood
  • Decreased blood pressure
  • Orthostatic hypotension (sudden lowering of blood pressure on standing)
  • Breathlessness
  • Vomiting
  • Abdominal pain

How to use Telfiga M 40mg/50mg Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to the advised dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Telfiga M 40mg/50mg Extended-Release Tablet should be administered with a meal.

How Telfiga M 40mg/50mg Tablet ER works:

Each Telfiga M 40mg/50mg Extended-Release tablet contains telmisartan and metoprolol succinate, working together to reduce blood pressure.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Telfiga M 40mg/50mg Extended-Release Tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Telfiga M 40mg/50mg tablets pose a confirmed risk to a developing fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Telfiga M 40mg/50mg tablets are likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.

DrivingDrivingUNSAFE

Extended-release Telfiga M 40mg/50mg tablets can cause drowsiness, blurred vision, and dizziness. Driving is prohibited if these effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

Patients with kidney disease can safely use Telfiga M 40mg/50mg Extended-Release tablets without any necessary dosage modification.

LiverLiverCAUTION

Patients with liver impairment should use Telfiga M 40mg/50mg Extended-Release tablets cautiously. Dosage modification of Telfiga M 40mg/50mg Extended-Release tablets may be necessary; physician consultation is advised.

What if you forget to take Telfiga M 40mg/50mg Tablet ER :

Should you forget a dose of Telfiga M 40mg/50mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Telfiga M 40mg/50mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category HEART

FAQs on Telfiga M 40mg/50mg Tablet ER

Telfiga 40mg/50mg ER Succinate tablets may cause dizziness, especially upon standing suddenly after sitting or lying down. To minimize this risk, rise slowly from a lying or sitting position.
Enhance your health while taking Telfiga M 40mg/50mg Tablet ER Succinate by adopting a healthier lifestyle. Quitting smoking significantly reduces your risk of heart attack and stroke. Weight management is crucial; aim for a healthy weight if you're overweight or obese. Incorporate fruits and vegetables into a balanced diet, and regular exercise strengthens your heart and lowers heart attack risk.
Continue taking your Telfiga M 40mg/50mg Tablet ER as prescribed, even if you feel healthy. Abruptly stopping this medication can cause serious health problems, including heart attack and stroke.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Telfiga M 40mg/50mg Table...
58
MRP 67
13% off